- Home>
- Specialties>
- Oncology and Hematology>
- Anemia
Search for Anemia in Oncology and Hematology
Physician-authored summaries on the latest research on anemia, editorials on anemia, and perspectives on anemia - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 64 results - Relevance
- Date
You searched for: anemia in Oncology and Hematology
-
Low-Dose Rituximab for Autoimmune Hemolytic Anemia
- February 14, 2012
- David Green, MD, PhD
- Oncology and Hematology
Overall response was 82.6% at 2 months after treatment.- Reviewing:
- Barcellini W et al., Blood 2012 Jan 20;:
-
Alemtuzumab for Severe Aplastic Anemia?
- December 6, 2011
- David Green, MD, PhD
- Oncology and Hematology
This humanized anti-CD52 monoclonal antibody was effective for patients with relapsed or refractory disease.- Reviewing:
- Scheinberg P et al., 2011 Nov 8;:
-
Long-Term Outlook After Hematopoietic Stem Cell Transplantation
- September 13, 2011
- David Green, MD, PhD
- Oncology and Hematology
Many patients survive to adulthood but are vulnerable to adverse health conditions.- Reviewing:
- Armenian SH et al., Blood 2011 Aug 4; 118:1413. Sanders JE et al., Blood 2011 Aug 4; 118:1421.
-
Horse ATG More Effective Than Rabbit ATG for Acquired Aplastic Anemia
- August 3, 2011
- David Green, MD, PhDhttp://oncology-hematology.jwatch.org/misc/board_about.dtl#aGreen
- Oncology and Hematology
Six-month response rates were about twice as high with horse antithymocyte globulin as with rabbit antithymocyte globulin, resulting in a survival advantage at 3 years.- Reviewing:
- Scheinberg P et al., N Engl J Med 2011 Aug 4; 365:430.
-
Vitamin D Deficiency and Anemia in Older Men and Women
- April 12, 2011
- David Green, MD, PhD
- Oncology and Hematology
VDD was associated with specific subtypes of anemia, particularly anemia of inflammation.- Reviewing:
- Perlstein TS et al., Blood 2011 Mar 10; 117:2800.
-
Granulocyte Colony-Stimulating Factor for Aplastic Anemia
- February 8, 2011
- David Green, MD, PhD
- Oncology and Hematology
Adding G-CSF to immunosuppressive therapy improved survival at 6 years in patients who achieved neutrophil counts ≥0.5×109/L at day 30.- Reviewing:
- Tichelli A et al., Blood 2011 Jan 13;:
-
Oral Iron Chelation Therapy for Aplastic Anemia
- October 19, 2010
- David Green, MD, PhD
- Oncology and Hematology
Deferasirox decreased iron levels effectively, but adverse events were common.- Reviewing:
- Lee JW et al., Blood 2010 Oct 7; 116:2448.
-
The Pathogenesis of Anemia in Patients with Hodgkin Lymphoma
- June 15, 2010
- David Green, MD, PhD
- Oncology and Hematology
Hepcidin and interleukin-6 play interrelated roles in the process.- Reviewing:
- Hohaus S et al., J Clin Oncol 2010 May 20; 28:2538.
-
Erythropoiesis-Stimulating Agents in Patients Undergoing Hemodialysis
- March 4, 2010
- David Green, MD, PhD
- Oncology and Hematology
These agents might help those who are severely anemic but could cause harm in others.- Reviewing:
- Brookhart MA et al., JAMA 2010 Mar 3; 303:857.
-
Plugging the Leak in Sickle Cells
- May 6, 2008
- David Green, MD, PhD
- Oncology and Hematology
Treatment with senicapoc, a Gardos-channel inhibitor, was associated with increased hemoglobin levels and attenuated cell dehydration and hemolysis in sickle cell patients.- Reviewing:
- Ataga KI et al., Blood 2008 Apr 15; 111:3991. Joiner CH., Blood 2008 Apr 15; 111:3918.
-
Darbepoetin for Anemia of Cancer
- March 18, 2008
- Barbara A. Murphy, MD
- Oncology and Hematology
In an international study, researchers failed to demonstrate a significant benefit for ESAs in patients with AoC who were not receiving myelosuppressive chemotherapy or radiotherapy.- Reviewing:
- Smith RE Jr et al., J Clin Oncol 2008 Mar 1; 26:1040.
-
Treatment of Aplastic Anemia
- October 16, 2007
- David Green, MD, PhD
- Oncology and Hematology
Adding G-CSF to standard therapy (ATG plus CyA) increased the percentage of patients who responded at 6 months.- Reviewing:
- Teramura M et al., Blood 2007 Sep 15; 110:1756.
-
Complete Correction of Anemia of Renal Failure Is Not Advised
- December 11, 2006
- David Green, MD, PhD
- Oncology and Hematology
Target Hb levels should not exceed 12 g/dL.- Reviewing:
- Drüeke TB et al., N Engl J Med 2006 Nov 16; 355:2071-84. Singh AK et al., N Engl J Med 2006 Nov 16; 355:2085-98.
-
Autoimmune Cytopenia: Effects and Treatments
- February 8, 2011
- David Green, MD, PhD
- Oncology and Hematology
AC in patients with chronic lymphocytic leukemia did not alter prognosis and responded to rituximab plus alemtuzumab.- Reviewing:
- Moreno C et al., Blood 2010 Dec 2; 116:4771. Gómez-Almaguer D et al., Blood 2010 Dec 2; 116:4783.
-
Lenalidomide plus Prednisone for Myelofibrosis?
- January 25, 2011
- David Green, MD, PhD
- Oncology and Hematology
A new phase II study reveals some limitations.- Reviewing:
- Mesa RA et al., Blood 2010 Nov 25; 116:4436.
-
Use of Erythropoiesis-Stimulating Agents for Chemotherapy Patients
- November 30, 2010
- David Green, MD, PhD
- Oncology and Hematology
Updated guidelines from the American Society of Hematology and the American Society of Clinical Oncology- Reviewing:
- Rizzo JD et al., Blood 2010 Nov 18; 116:4045.
-
Azacitidine for Myelodysplasia
- November 23, 2010
- David Green, MD, PhD
- Oncology and Hematology
Responses were seen in 43% of patients.- Reviewing:
- Itzykson R et al., Blood 2010 Oct 12;:
-
Oral Therapy for Gaucher Disease Type 1
- September 14, 2010
- David Green, MD, PhD
- Oncology and Hematology
A new glucosylceramide-synthesis inhibitor provided benefits with minimal adverse effects.- Reviewing:
- Lukina E et al., Blood 2010 Aug 12; 116:893.
-
Sickle Cell Disease and Cardiopulmonary Effects
- August 17, 2010
- David Green, MD, PhD
- Oncology and Hematology
Two studies reveal possible pathways.- Reviewing:
- Johnson MC et al., Blood 2010 Jul 8; 116:16. Sundaram N et al., Blood 2010 Jul 8; 116:109.
-
Erythropoietin for Myelodysplastic Syndromes
- October 20, 2009
- David Green, MD, PhD
- Oncology and Hematology
Correction of anemia was safe and improved quality of life.- Reviewing:
- Greenberg PL et al., Blood 2009 Sep 17; 114:2393.
Sort by:
Items 1 to 20 of 64 results - Relevance
- Date
